Dipeptedyl peptidase-4 (DPP-4) inhibitor downregulates HMGB1/TLR4/NF- ?B signaling pathway in a diabetic rat model of non-alcoholic fatty liver disease

.

Source: Archives of Physiology and Biochemistry - September 20, 2021 Category: Physiology Authors: Mona M. Allam Reham M. Ibrahim Walaa Bayoumie El Gazzar Mona A. Said Source Type: research